Essential Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Essential Partners's CDNA Position: Q2 2026 in Review
Essential Partners increased its CareDx (CDNA) stake by 0.33% in Q2 2026, buying an estimated $22 and bringing the position to 304 shares worth $8.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1286.
Essential Partners first reported a position in CDNA in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Essential Partners held 304 shares of CareDx worth $8.66K as of Q2 2026.
- Essential Partners bought 1 CareDx share in Q2 2026, an estimated $22.
- CareDx made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1286 holding.
- Essential Partners first reported a position in CareDx in Q2 2025 and has held it in 5 quarters since.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.